STOCK TITAN

Ives Ultra AI: YA II reports about 9.4% stake

YA II says it intends to exercise the option on or immediately following December 30, 2026, when it becomes exercisable.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Ives Ultra AI Opportunities Inc. is the issuer in a Schedule 13D by YA II PN, Ltd., YA Global Investments II (U.S.), LP, Yorkville Advisors Global, LP, Yorkville Advisors Global II, LLC, YAII GP, LP, YAII GP II, LLC, and Mark Angelo, Partner and President of Yorkville Advisors Global. YA II reports beneficial ownership of 2,500,000 shares; the other reporting persons may be deemed to own the same position, approximately 9.4% of the 26,500,000 shares outstanding as of October 1, 2026. The shares are distributable to YA II after exercise of its option.

Under a September 2, 2026 Option Agreement with Ultra AI Holdings LLC, which holds 5,000,000 issuer shares, YA II may pay $100,000 for newly issued membership interests that would give it 50% of the LLC; it may then demand distribution of 2,500,000 shares. The option becomes exercisable on December 30, 2026, and YA II intends to exercise and seek distribution on or immediately afterward. The reporting persons intend further discussions with the issuer’s board and management and may propose changes, including a sale of the issuer, depending on stated factors.

Filing Explained

YA II has the right to appoint one member to the board of managers of Ives Ultra Capital Management, the issuer’s investment manager, and has appointed Dan Ives, an employee of a YA II affiliate; this is a role at the investment manager, not the issuer’s board.

Beneficially owned shares 2,500,000 shares Shares distributable to YA II upon exercise of its option
Reported ownership Approximately 9.4% Based on 26,500,000 shares outstanding as of October 1, 2026
Shares outstanding 26,500,000 shares As of October 1, 2026
Shares held by Ultra AI Holdings LLC 5,000,000 shares Issuer shares held by the Grantor
Option exercise price $100,000 Exercise price under the Option Agreement
Membership interest upon exercise 50% YA II’s interest in Ultra AI Holdings LLC upon exercise
Option exercisability date December 30, 2026 Option becomes exercisable
beneficially owns regulatory
"YA II beneficially owns 2,500,000 Shares distributable to it by the Grantor"
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
newly issued membership interests financial
"option to acquire newly issued membership interests in the Grantor"
pro rata share financial
"distribution of its pro rata share of the Shares owned by the Grantor"
Pro rata share is the portion of an asset, liability, income, loss, or new securities that an individual or entity receives based on their proportional ownership, contribution, or entitlement. It matters to investors because it determines how returns, dilution, distributions, or obligations are divided—think of slicing a pie so each person gets a piece sized exactly to the fraction of the whole they own.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IVAI shares does YA II report beneficially owning?

YA II PN, Ltd. reports beneficial ownership of 2,500,000 shares, approximately 9.4% of the class. The percentage is based on 26,500,000 shares outstanding as of October 1, 2026. The other reporting persons may be deemed to own the same shares.

When can YA II exercise its option for IVAI shares?

The option becomes exercisable on December 30, 2026, 90 days after the issuer’s IPO closed on October 1, 2026. YA II says it intends to exercise the option and demand distribution of its pro rata share of the LLC’s shares on or immediately following December 30.

What plans do the IVAI reporting persons disclose?

The reporting persons intend to continue communications with the issuer’s board and management. Depending on factors including the issuer’s financial position and investment strategy, share-price levels, and market and economic conditions, they may propose changes to capital allocation, capitalization, ownership, board structure or operations, including a sale of the issuer as a whole or in parts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





90386L108

(CUSIP Number)
James T. Seery
Duane Morris LLP, 22 Vanderbilt, 335 Madison Avenue, 23rd Floor
New York, NY, 10017
(973) 424-2088

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
10/31/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Rows 8, 10 and 11 Represents Shares issuable upon exercise of an option to purchase membership interests in Ultra AI Holdings LLC, which holds 5,000,000 Shares, and the subsequent distribution of 2,500,000 Shares, which option is exercisable within 60 days. Row 13 Based on 26,500,000 Shares outstanding as of October 1, 2026, as reported in the Issuer's Prospectus dated September 29, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Rows 8, 10 and 11 Represents Shares issuable upon exercise of an option to purchase membership interests in Ultra AI Holdings LLC, which holds 5,000,000 Shares, and the subsequent distribution of 2,500,000 Shares, which option is exercisable within 60 days. Row 13 Based on 26,500,000 Shares outstanding as of October 1, 2026, as reported in the Issuer's Prospectus dated September 29, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Rows 8, 10 and 11 Represents Shares issuable upon exercise of an option to purchase membership interests in Ultra AI Holdings LLC, which holds 5,000,000 Shares, and the subsequent distribution of 2,500,000 Shares, which option is exercisable within 60 days. Row 13 Based on 26,500,000 Shares outstanding as of October 1, 2026, as reported in the Issuer's Prospectus dated September 29, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Rows 8, 10 and 11 Represents Shares issuable upon exercise of an option to purchase membership interests in Ultra AI Holdings LLC, which holds 5,000,000 Shares, and the subsequent distribution of 2,500,000 Shares, which option is exercisable within 60 days. Row 13 Based on 26,500,000 Shares outstanding as of October 1, 2026, as reported in the Issuer's Prospectus dated September 29, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Rows 8, 10 and 11 Represents Shares issuable upon exercise of an option to purchase membership interests in Ultra AI Holdings LLC, which holds 5,000,000 Shares, and the subsequent distribution of 2,500,000 Shares, which option is exercisable within 60 days. Row 13 Based on 26,500,000 Shares outstanding as of October 1, 2026, as reported in the Issuer's Prospectus dated September 29, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Rows 8, 10 and 11 Represents Shares issuable upon exercise of an option to purchase membership interests in Ultra AI Holdings LLC, which holds 5,000,000 Shares, and the subsequent distribution of 2,500,000 Shares, which option is exercisable within 60 days. Row 13 Based on 26,500,000 Shares outstanding as of October 1, 2026, as reported in the Issuer's Prospectus dated September 29, 2026.


SCHEDULE 13D




Comment for Type of Reporting Person:
Rows 8, 10 and 11 Represents Shares issuable upon exercise of an option to purchase membership interests in Ultra AI Holdings LLC, which holds 5,000,000 Shares, and the subsequent distribution of 2,500,000 Shares, which option is exercisable within 60 days. Row 13 Based on 26,500,000 Shares outstanding as of October 1, 2026, as reported in the Issuer's Prospectus dated September 29, 2026.


SCHEDULE 13D


YA II PN, Ltd.
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/30/2026
YA Global Investments II (U.S.), LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/30/2026
Yorkville Advisors Global, LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/30/2026
Yorkville Advisors Global II, LLC
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/30/2026
YAII GP, LP
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/30/2026
YAII GP II, LLC
Signature:/s/ David Gonzalez
Name/Title:David Gonzalez, General Counsel
Date:10/30/2026
Mark Angelo
Signature:/s/ Mark Angelo
Name/Title:Mark Angelo
Date:10/30/2026

Keep reading